Unlocking Biomedical Insights: Hierarchical Attention Networks for High-Dimensional Data Interpretation

TL;DR

This paper introduces HAIN, a hierarchical attention network that enhances interpretability and accuracy in analyzing high-dimensional biomedical data, facilitating clinical insights and decision-making.

Contribution

The paper presents a novel hierarchical attention-based architecture that combines multi-level attention, dimensionality reduction, and explanation-driven loss for interpretable biomedical data analysis.

Findings

Achieves 94.3% classification accuracy on TCGA dataset.

Outperforms SHAP and LIME in interpretability and transparency.

Effectively identifies biologically relevant cancer biomarkers.

Abstract

The proliferation of high-dimensional datasets in fields such as genomics, healthcare, and finance has created an urgent need for machine learning models that are both highly accurate and inherently interpretable. While traditional deep learning approaches deliver strong predictive performance, their lack of transparency often impedes their deployment in critical, decision-sensitive applications. In this work, we introduce the Hierarchical Attention-based Interpretable Network (HAIN), a novel architecture that unifies multi-level attention mechanisms, dimensionality reduction, and explanation-driven loss functions to deliver interpretable and robust analysis of complex biomedical data. HAIN provides feature-level interpretability via gradientweighted attention and offers global model explanations through prototype-based representations. Comprehensive evaluation on The Cancer Genome Atlas (TCGA) dataset demonstrates that HAIN achieves a classification accuracy of 94.3%, surpassing conventional post-hoc interpretability approaches such as SHAP and LIME in both transparency and explanatory power. Furthermore, HAIN effectively identifies biologically relevant cancer biomarkers, supporting its utility for clinical and research applications. By harmonizing predictive accuracy with interpretability, HAIN advances the development of transparent AI solutions for precision medicine and regulatory compliance.